Abstract
In the rush to develop anti-viral drugs against the human immunodeficiency virus type I (HIV-1), all the steps of the viral life cycle are potential targets of therapeutic intervention. In this review, we will explore the recent advances on strategies that aim at obstructing the formation, the release and the infectivity of newly formed virion particles from HIV-1 infected cells.
Keywords: drugs, anti-viral approaches, virion assembly, hiv-1, retrovirus
Current Pharmaceutical Design
Title: Targeting the Assembly of the Human Immunodeficiency Virus Type I
Volume: 10 Issue: 30
Author(s): D. Muriaux, J. L. Darlix and A. Cimarelli
Affiliation:
Keywords: drugs, anti-viral approaches, virion assembly, hiv-1, retrovirus
Abstract: In the rush to develop anti-viral drugs against the human immunodeficiency virus type I (HIV-1), all the steps of the viral life cycle are potential targets of therapeutic intervention. In this review, we will explore the recent advances on strategies that aim at obstructing the formation, the release and the infectivity of newly formed virion particles from HIV-1 infected cells.
Export Options
About this article
Cite this article as:
Muriaux D., Darlix L. J. and Cimarelli A., Targeting the Assembly of the Human Immunodeficiency Virus Type I, Current Pharmaceutical Design 2004; 10 (30) . https://dx.doi.org/10.2174/1381612043382701
DOI https://dx.doi.org/10.2174/1381612043382701 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies
Reviews on Recent Clinical Trials Therapeutic Perspectives for cN-II in Cancer.
Current Medicinal Chemistry Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Synthesis of a Tyr-Tyr Dipeptide Library and Evaluation Against Tumor Cells
Medicinal Chemistry P-glycoprotein Inhibition: The Past, the Present and the Future
Current Drug Metabolism Precision Mechanics with Multifunctional Tools: How HnRNP K and HnRNPs E1/E2 Contribute to Post-Transcriptional Control of Gene Expression in Hematopoiesis
Current Protein & Peptide Science MicroRNAs and Cancer; an Overview
Current Pharmaceutical Biotechnology Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
Current Pharmaceutical Biotechnology A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Current Pharmaceutical Design Modelling and Measuring Redox Cycling and Cytotoxicity of Quinones
Drug Metabolism Letters DNA Intercalators in Cancer Therapy: Organic and Inorganic Drugs and Their Spectroscopic Tools of Analysis
Mini-Reviews in Medicinal Chemistry Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Improving Safety of Gene Therapy
Current Drug Safety Bhasma: Indian Perspective of Nanomedicinal Technology
Recent Patents on Nanomedicine Towards Liver-Directed Gene Therapy for Crigler-Najjar Syndrome
Current Gene Therapy MicroRNA Expression in Coronary Artery Disease
MicroRNA